BAT acquires stake in German cannabis company Sanity Group

BAT acquires stake in German cannabis company Sanity Group
British American Tobacco acquires minority stake in German cannabis firm Sanity Group, continuing its exploration into non-nicotine areas.

BAT, through one of its wholly-owned subsidiaries, has acquired a non-controlling minority stake in Sanity Group, one of Germany's leading cannabis companies.

I'm sorry, but "Greenserenityca" does not make sense as a sentence or phrase in English, and therefore cannot be translated into standard journalistic English. Please provide a valid sentence or phrase to be translated.

This investment is a supplement to other recent investments made by BAT, the most notable being the strategic research and development partnership announced with Canada's Organigram Holdings in March of last year.

The Sanity Group, headquartered in Berlin, produces both consumer-focused CBD brands and medical cannabis brands, with a strong record of research, development, and marketing in the cannabis industry.

Kingsley Wheaton, the Chief Growth Officer of BAT, stated in a press release that the investment in Sanity Group is another example of BAT's exploration beyond nicotine and lays the foundation for BAT's future growth in various categories and regions.

We will continue to transform our business by better understanding our current and future consumers, which is part of our 'Better Tomorrow' objective.

Sanity, according to its founder and CEO Finn Age Hansel, has secured $37.6 million in funding during the second round of financing led by BAT. Approximately half of the funds will be allocated to strengthening Sanity's medical businesses while the remaining funds will be directed towards preparing for possible legalization of recreational marijuana in Germany.

Germany has not yet legalized recreational marijuana, but it is expected to do so sooner or later. Hansel stated that the German coalition government is "actively working" and "really hopes to develop a good draft law by the end of this year." "This is indeed a government priority.

This funding is an important milestone for us and a strong signal for the future of cannabis in Germany and Europe," said Max Narr, Chief Investment Officer of Sanity Group. "In the midst of a challenging global economy, we are proud to have secured such a significant amount of financing.


This article is compiled from third-party information and is intended for industry-related communications and learning purposes only.

This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the truthfulness and accuracy of the article's content. The compilation of this article is only intended for industry exchange and research.

Due to limitations in our translation abilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.

2FIRSTS maintains complete alignment with the Chinese government concerning any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.

The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.